Effects of soy protein isolate (SPI) and casein on the postprandial lipemia in normolipidemic men

Journal of Nutritional Science and Vitaminology

Volumn 44, Issue 1, 1998, Pages 113-127

  Shige, Hideki ^a   Ishikawa, Toshitsugu ^a   Higashi, Kenji ^a   Yamashita, Takeshi ^a   Tomiyasu, Koji ^a   Yoshida, Hiroshi ^a   Hosoai, Hiroshi ^a   Ito, Toshimitsu ^a   Nakajjma, Kei ^a   Ayaori, Makoto ^a   Yonemura, Atsushi ^a   Suzukawa, Michio ^a   Nakamura, Haruo ^a  

^a NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

Author keywords

Casein; Normolipidemic male subjects; Postprandial lipemia; Remnant lipoprotein; Soybean protein

Indexed keywords

APOLIPOPROTEIN; CASEIN; CHOLESTEROL; LIPID; MILK FAT; SOYBEAN PROTEIN; TRIACYLGLYCEROL;

ADULT; AREA UNDER THE CURVE; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; ENZYME IMMUNOASSAY; HUMAN; HUMAN EXPERIMENT; HYPERLIPIDEMIA; MALE; POSTPRANDIAL STATE; TURBIDIMETRY;

EID: 7144242314     PISSN: 03014800     EISSN: 18817742     Source Type: Journal    
DOI: 10.3177/jnsv.44.113     Document Type: Article

References (41)

1. Castelli WP, Garrison RJ, Wilson PW, Abbott RD, Kalousdian S, Kannel WB. 1986. Incidence of coronary heart disease and lipoprotein cholesterol levels: the Framingham study. JAMA 256: 2835-2838.
2. Simons LA, Dwyer T, Simons J, Bernstein L, Mock P, Poonia NS, Balasubramaniam S, Baron D, Barnson J, Morgan J, Roy P. 1987. Chylomicrons and chylomicron remnants in coronary artery disease: a case control study. Atherosclerosis 65: 181-189.
3. Simpson HS, Williamson CM, Olivecrona T, Pringle S, Maclean J, Lorimer AR, Bonnefous F, Bogaievsky Y, Packard CJ, Shepherd J. 1990. Postprandial lipemia, fenofibrate and coronary artery disease. Atherosclerosis 85: 193-202.
4. Groot PHE, Stiphout WAH, Krauss XH, Jansen H, Tol A, Ramshorst E, Chin-on S, Hofman A, Cresswell SR, Havekes L. 1991. Postprandial lipoprotein metabolism in normolipidemic men with and without coronary artery disease. Arterioscler Thromb 11: 653-662.
5. Patsch JR, Meisenbock G, Hopferwieser T, Muhlberger V, Knapp E, Dunn JK, Gotto AM Jr, Patsch W. 1992. Relation of triglyceride metabolism and coronary disease. Arterioscler Thromb 12: 1336-1345.
6. Karpe F, Steiner G, Uffelman K, Olivecorna T, Hamsten A. 1994. Postprandial lipoprotein and progression of coronary atherosclerosis. Atherosclerosis 106: 83-97.
7. Sharrett AR, Chambless LE, Heiss G, Paton CC, Patsch W. 1995. Association of postprandial triglyceride and retinyl palmitate responses with asymptomatic carotid artery atherosclerosis in middle-aged men and women. Arterioscler Thromb Vasc Biol 15: 2122-2129.
8. Ginsberg HN, Jones J, Blaner WS, Thomas A, Karmally W, Fields L, Blood D, Begg MD. 1995. Association of postprandial triglyceride and retinyl palmitate responses with newly diagnosed exercise-induced myocardial ischemia in middle-aged men and women. Arterioscler Thromb Vasc Biol 15: 1829-1838.
9. Nakamura H, Ikewaki K, Nishiwaki M, Shige H. 1995. Postprandial hyperlipemia and coronary artery disease. Ann New York Acad Sci 748: 441-446.
10. Goldberg AP, Lim A, Kolar JB, Grundhauser JJ, Steinke FH, Schonfeld G. 1982. Soybean protein independently lowers plasma cholesterol levels in primary hypercholesterolemia. Atherosclerosis 43: 355-368.
11. Erdman JW Jr, Fordyce EJ. 1989. Soy products and the human diet. Am J Clin Nutr 49: 725-737.
12. Sirtori CR, Lovati MR, Manzoni C, Monetti M, Pazzucconi F, Gatti E. 1995. Soy and cholesterol reduction: clinical experience. J Nutr 125: 598S-605S.
13. Anderson JW, Johnstone BM, Cook-Newell ME. 1995. Meta-analysis of the effects of soy protein on serum lipids. N Engl J Med 333: 276-282.
14. Sirtori CR, Galli G, Lovati MR, Carrara P, Bosisio E, Galli-Kienle M. 1984. Effects of dietary proteins on the regulation of liver lipoprotein receptors in rat. J Nutr 114: 1493-1500.
15. Chon JS, Nestel PJ. 1985. Hepatic lipoprotein receptor activity in rat fed casein and soy protein. Atherosclerosis 56: 247-250.
16. Lovati MR, Manzoni C, Canavesi A, Sirtori M, Vaccarino V, March M, Gaddi G, Sirtori CR. 1987. Soybean protein diet increased low density lipoprotein receptor activity in mononuclear cells from hypercholesterolemic patients. J Clin Invest 80: 1498-1502.
17. Gaddi A, Ciarocchi A, Matteucci A, Rimondi S, Ravaglia G, Descovich GC, Sirtori CR. 1991. Dietary treatment for familial hypercholesterolemia-differential effects of dietary soy protein according to the apolipoprotein E phenotype. Am J Clin Nutr 53: 1191-1196.
18. Huff MW, Carroll KK. 1980. Effects of dietary protein on turnover, oxidation and absorption of cholesterol, and on steroid excretion in rabbits. J Lipid Res 21: 546-558.
19. Vahouny GV, Chalcarz W, Satchitanandam S, Adamson I, Klurfeld DM, Krichevski D. 1984. Effect of soy protein and casein intake on intestinal absorption and lymphatic transport of cholesterol and oleic acid. Am J Clin Nutr 40: 1156-1164.
20. Ho HT, Kim DN, Lee KT. 1989. Intestinal apolipoprotein B-48 synthesis and lymphatic cholesterol transport are lower in swine fed high fat, high cholesterol diet with soy protein than with casein. Atherosclerosis 77: 15-23.
21. Vessby B, Karlstrom B, Lithell H, Gustafsson IB, Werner I. 1982. The effects on lipid and carbohydrate metabolism of replacing some animal protein by soy protein in a lipid-lowering diet for hypercholesterolemic patients. Human Nutr Appl Nutr 36: 179-189.
22. Forsythe WA. 1986. Comparison of dietary casein or soy protein effects on plasma lipids and hormone concentration in the gerbil. J Nutr 116: 1165-1171.
23. Havel RJ. 1995. Chylomicron remnants: hepatic receptors and metabolism. Curr Opin Lipidol 6: 312-316.
24. Howard BV. 1987. Lipoprotein metabolism in diabetes mellitus. J Lipid Res 28: 613-628.
25. Campos E, Nakajima K, Tanaka A, Havel RJ. 1992. Properties of an apolipoprotein E-enriched fraction of triglyceride-rich lipoprotein isolated from human blood plasma with a monoclonal antibody to apolipoprotein B-100. J Lipid Res 33: 369-380.
26. Schneeman BO, Kotite L, Todd KM, Havel RJ. 1993. Relationships between the response of triglyceride-rich lipoproteins in blood plasma containing apolipoproteins B-48 and B-100 to a fat-containing meal in normolipidemic humans. Proc Natl Acad Sci USA 90: 2069-2073.
27. Nakajima K, Saito T, Tamura A, Suzuki M, Nakano T, Adachi M, Tanaka A, Tada N, Nakamura H, Campos E, Havel RJ. 1993. Cholesterol in remnant-like lipoprotein in human using monoclonal anti apo B-100 and anti apo A-1 immunoaffinity mixed gels. Clin Chim Acta 233: 53-71.
28. Shimizu H, Mori M, Saito T. 1993. An increase of serum remnant-like particles in non-insulin-dependent diabetic patients with microalbuminemia. Clin Chim Acta 221: 191-196.
29. Nakajima K, Saito T, Tamura A, Suzuki M, Nakano T, Adachi M, Tanaka A, Tada N, Nakamura H, Murase T. 1994. A new approach for the detection of type III hypertriglyceridemia by RLP-cholesterol assay. J Atheroscl Thromb 1: 30-36.
30. Nishiwaki M, Ishikawa T, Homma Y, Tada N, Kagami A, Ohshima K, Itoh T, Tomiyasu K, Shige H, Miyajima E, Nakamura H. 1994. Effect of pravastatin on plasma lipids, apolipoproteins. Lp(a), remnant-like particle, cholesteryl ester transfer protein, and lecithin: cholesterol acyltransferase (LCAT); a 12-month study. Nutr Metab Cardiovasc Dis 4: 10-15.
31. Shige H, Ishikawa T, Ikewaki K, Nishiwaki M, Higashi K, Nakajima K, Nakamura H. 1997. Remnant-like VLDL isolated from hypertriglyceridemic patients by immunoaffinity chromatography suppressed 3-hydroxyl-3-methylglutaryl coenzyme A activity of cultured human skin fibroblasts. Clin Chim Acta 258: 145-158.
32. Nakamura H, Miyajima E, Ikewaki K. 1989. Effects of soy protein diet (20g/day) on plasma and lipoprotein lipids based on apo E phenotypes (in Japanese). Nutr Sd Soy Protein Jpn 10: 89-93.
33. Jacques H, Laurin D, Moorjani S, Steinke FH, Gagne C, Brun D, Lupien PJ. 1992. Influence of diets containing cow's milk or soy protein beverage on plasma lipids in children with familial hypercholesterolemia. J Am Coll Nutr 11: 69S-73S.
34. D'Amico G, Gentile MG, Manna G, Fellin G, Ciceri R, Cofano F, Petrini C, Lavarda F, Perolini S, Porrini M. 1992. Effect of vegetarian soy diet on hyperlipidemia in nephrotic syndrome. Lancet 339: 1131-1134.
35. D'Amico G, Gentile MG. 1993. Influence of diet on lipid abnormalities in human renal disease. Am J Kidney Dis 22: 151-157.
36. Patsch JR, Karlin JB, Scott LW, Smith LC, Gotto AM Jr. 1983. Inverse relationship between blood levels of high density lipoprotein subfraction 2 and magnitude of postprandial lipemia. Proc Natl Acad Sci USA 80: 1449-1453.
37. Kim DN, Lee KT, Reiner JM, Thomas WA. 1980. Increased steroid excretion in swine fed high-fat, high-cholesterol diet with soy protein. Exp Mol Pathol 33: 25-35.
38. Wolfe BM, Grace DM. 1987. Substitution of mixed amino acids resembling soy protein for mixed amino acids resembling casein in the diet reduces plasma cholesterol in slowly, but not rapidly fed nor fasted baboons. Metabolism 36: 223-229.
39. Krichevski D. 1990. Protein and atherosclerosis. J Nutr Sci Vitamin 36: S81-S86.
40. Lovati MR, Manzoni C, Corsini A, Granata A, Frattini R, Fumagalli R, Sirtori AR. 1992. Low-density lipoprotein receptor activity is modulated by soybean globulins in cell cultures. J Nutr 122: 1971-1978.
41. Anthony MS, Clarkson TB, Hughes CL Jr, Morgan TM, Burke GL. 1996. Soybean isoflavons improve cardiovascular risk factors without affecting the reproductive system of peripubertal rhesus monkeys. J Nutr 126: 43-50.